UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Vaccine, 2014-09, Vol.32 (42), p.5496-5502

2014

Volltextzugriff (PDF)

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

The New England journal of medicine, 2017-06, Vol.376 (25), p.2427-2436

2017

Volltextzugriff (PDF)

Recombinant protein vaccines produced in insect cells

Vaccine, 2012-02, Vol.30 (10), p.1759-1766

Cox, Manon M.J

2012

Volltextzugriff (PDF)

Titer on chip: new analytical tool for influenza vaccine potency determination

PloS one, 2014-10, Vol.9 (10), p.e109616-e109616

2014

Volltextzugriff (PDF)

Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production

Vaccines (Basel), 2021-12, Vol.9 (12), p.1504

Cox, Manon M J

2021

Volltextzugriff (PDF)

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

Vaccine, 2012-08, Vol.30 (36), p.5407-5416

2012

Volltextzugriff (PDF)

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

BMC biotechnology, 2012-10, Vol.12 (1), p.77-77, Article 77

2012

Volltextzugriff (PDF)

A fast track influenza virus vaccine produced in insect cells

Journal of invertebrate pathology, 2011-07, Vol.107, p.S31-S41

2011

Volltextzugriff (PDF)

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age

Vaccine, 2015-11, Vol.33 (48), p.6622-6628

2015

Volltextzugriff (PDF)

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

Vaccine, 2006-03, Vol.24 (12), p.2176-2185

2006

Volltextzugriff (PDF)

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Biotechnology and bioengineering, 2015-11, Vol.112 (11), p.2267-2275

2015

Volltextzugriff (PDF)

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate

Vaccine, 2015-11, Vol.33 (44), p.6011-6016

2015

Volltextzugriff (PDF)

FluBlok, a recombinant hemagglutinin influenza vaccine

Influenza and other respiratory viruses, 2008-11, Vol.2 (6), p.211-219

2008

Volltextzugriff (PDF)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine

Human vaccines & immunotherapeutics, 2017-06, Vol.13 (6), p.1261-1271

2017

Volltextzugriff (PDF)

Dose-Related Safety and Immunogenicity of a Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults

The Journal of infectious diseases, 2006-05, Vol.193 (9), p.1223-1228

2006

Volltextzugriff (PDF)

Expansion and Storage of Insect Cells and Virus Stocks

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.3

Cox, Manon M J

2024

Volltextzugriff (PDF)

Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age

The Journal of infectious diseases, 2017-12, Vol.216 (10), p.1219-1226

2017

Volltextzugriff (PDF)

Evaluation of the Virus Counter ® for rapid baculovirus quantitation

Journal of virological methods, 2011-01, Vol.171 (1), p.111-116

2011

Volltextzugriff (PDF)

Baculovirus-expressed influenza vaccine: a novel technology for safe and expeditious vaccine production for human use

Expert opinion on investigational drugs, 2007-07, Vol.16 (7), p.927-934

2007

Volltextzugriff (PDF)

FluBlok, a next generation influenza vaccine manufactured in insect cells

Biologicals, 2009-06, Vol.37 (3), p.182-189

2009

Volltextzugriff (PDF)

Innovations in vaccine development: can regulatory authorities keep up?

Expert review of vaccines, 2012-10, Vol.11 (10), p.1171-1173

2012

Volltextzugriff (PDF)

Glycobiotechnology of the Insect Cell-Baculovirus Expression System Technology

Advances in Glycobiotechnology, 2021, p.71-92

2021

Volltextzugriff (PDF)

Development of recombinant protein-based influenza vaccine Expression and affinity purification of H1N1 influenza virus neuraminidase

Journal of chromatography, 2006-12, Vol.1136 (1), p.48-56

2006

Volltextzugriff (PDF)

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults

Therapeutic advances in vaccines, 2015-07, Vol.3 (4), p.97-108

2015

Volltextzugriff (PDF)

Influenza viral neuraminidase: the forgotten antigen

Expert review of vaccines, 2011-12, Vol.10 (12), p.1683-1695

2011

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(58)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(41)
Humans
(31)
Influenza
(24)
Vaccines
(24)
Baculovirus
(22)
Animals
(21)
Influenza Vaccines - Immunology
(19)
Antigens
(16)
Female
(16)
Male
(16)
Immunology
(15)
Aged
(14)
Cell Culture
(12)
Influenza, Human - Prevention & Control
(12)
Middle Aged
(12)
Viruses
(12)
Medicine, Research & Experimental
(11)
Proteins
(11)
Research & Experimental Medicine
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

Recombinant protein vaccines produced in insect cells

Titer on chip: new analytical tool for influenza vaccine potency determination

Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

A fast track influenza virus vaccine produced in insect cells

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate

FluBlok, a recombinant hemagglutinin influenza vaccine

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine

Dose-Related Safety and Immunogenicity of a Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults

Expansion and Storage of Insect Cells and Virus Stocks

Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age

Evaluation of the Virus Counter ® for rapid baculovirus quantitation

Baculovirus-expressed influenza vaccine: a novel technology for safe and expeditious vaccine production for human use

FluBlok, a next generation influenza vaccine manufactured in insect cells

Innovations in vaccine development: can regulatory authorities keep up?

Glycobiotechnology of the Insect Cell-Baculovirus Expression System Technology

Development of recombinant protein-based influenza vaccine Expression and affinity purification of H1N1 influenza virus neuraminidase

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults

Influenza viral neuraminidase: the forgotten antigen

Suchergebnisse filtern